Significance of Expression of IMP3, PPARG & PD-L1 in Urothelial Carcinoma (Immunohistochemical Study)

EpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study

Significance of expression of VEGF, BCL-2, p63 and β‑hCG in gestational trophoblastic diseases.

Significance of CXCL9 and Vascular endothelial growth factor-α (VEGF-α) expression in Colorectal adenocarcinoma :(Immunohistochemical Study)

The Diagnostic and Prognostic Significance of ARID1A and CD8+ Expression in Endometrial Hyperplasia and Endometrial Endometrioid Adenocarcinoma (Immunohistochemical study)

CLINICOPATHOLOGICAL SIGNIFICANCE OF PROGRAMED DEATH -LIGAND -1(PD-L1) AND PROLIFERATION CELL NUCLEAR ANTIGE(PCNA)EXPRESSION IN PROSTATIC CARCINOMA; AN IMMUNOHISTOCHEMICAL STUDY"

CD8&CD163 EXPRESSION IN TUMOR MICROENVIRONMENT OF RENAL CELL CARCINOMA AND THEIR RELATION TO PD-L1 EXPRESSION

Evaluation of Histopathological and Prognostic Significance of Programmed Death Ligand 1 (PD-L1) Expression of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma

The Prognostic Value of CD133 in Ovarian Surface Epithelial Tumors

Value of Insulin-like Growth Factor II m-RNA-Binding Protein 3 (IMP3) Expression in Serous Ovarian Tumors: An immunohistochemical study